- Tickers in this article:
- NVAX
Drug developer Novavax to offer 6.8 million shares of common stock at $3.30 each; stock falls
11/20/09 - 10:36 AM EST
Biotech Stock Mailbag: FDA Playbook
Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.
11/20/09 - 06:01 AM EST
Earnings Preview: Dell Slips Even As PCs Rebound
Dell slips to No. 3 after HP, Acer in global PC shipments in 3Q, businesses still not spending
11/17/09 - 04:45 PM EST
Advice To Congress: Be Clear, Fair On Health Care
Americans' advice to Congress on health care: Be clear and fair about medical coverage
11/16/09 - 06:05 AM EST
Pfizer to Begin Selling Generics in Japan
- Tickers in this article:
- PFE
Pfizer plans to start selling generic drugs in Japan beginning in 2011, a spokesman said, according to reports.
11/19/09 - 12:39 AM EST
MedAssets Charts: In the Sweet Spot
- Tickers in this article:
- MDAS
The software company can reap the benefits of the Obama administration's emphasis on streamlining the health care system.
11/18/09 - 01:32 PM EST
U.S. Sees Low Demand for BioCryst Flu Drug
Peaking flu season could mean no need for further peramivir orders.
11/18/09 - 11:12 AM EST
Drugmakers' Differences: Analyst's Toolkit
Pharmaceutical companies require their own metrics of evaluation. Sanofi, which looks strong in some ways, comes across as risky in others.
11/18/09 - 05:00 AM EST
Another Genzyme Drug Goes Kaboom: BioBuzz
Company halts development of kidney disease drug following poor test results.
11/18/09 - 08:05 AM EST
Vivus Seeks Faster ED Drug: Biobuzz
Company says ED drug met all goals in phase III study.
11/18/09 - 06:42 AM EST
Genzyme's Termeer: Worst Biotech CEO of '09
Genzyme CEO Henri Termeer is Adam Feuerstein's Worst Biotech CEO of the Year for 2009.
11/17/09 - 12:31 PM EST
Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz
Mipomersen lowers cholesterol but not without liver side effects.
11/17/09 - 10:56 AM EST
Connect with TheStreet